Ensysce Biosciences (ENSCW) Preferred Dividend Payments (2022 - 2024)
Ensysce Biosciences (ENSCW) reported Preferred Dividend Payments of $290.0 for Q1 2024, down 96.51% year-over-year from $8309.0 in Q2 2023, and down 67.74% quarter-over-quarter from $899.0 in Q4 2023.
Ensysce Biosciences (ENSCW) Preferred Dividend Payments (2022 - 2024) Analysis & Trends
Ensysce Biosciences (ENSCW) has 3 years of Preferred Dividend Payments data on file, last reported at $290.0 in Q1 2024.
- Preferred Dividend Payments for Q1 2024 came in at $290.0, down 96.51% year-over-year; the trailing twelve-month figure through Dec 2024 was $290.0 (down 97.76% YoY), and the FY2024 annual result was $290.0, down 97.76% from the prior year.
- Preferred Dividend Payments fell to $290.0 in Q1 2024 per ENSCW's latest filing, from $899.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $715579.0 in Q1 2022 and troughed at $290.0 in Q1 2024.
- A 3-year average of $115803.8 and a median of $19957.5 in 2022 frame the typical range for Preferred Dividend Payments.
- On a YoY basis, Preferred Dividend Payments climbed as much as 96.36% in 2023 and fell as far as 98.84% in 2023.
- A 3-year view of Preferred Dividend Payments shows it stood at $31606.0 in 2022, then slumped by 97.16% to $899.0 in 2023, then slumped by 67.74% to $290.0 in 2024.
- Business Quant data shows ENSCW's Preferred Dividend Payments at $290.0 in Q1 2024, $899.0 in Q4 2023, and $3729.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ensysce Biosciences | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 290.00 |
| Dec 31, 2023 | 899.00 |
| Jun 30, 2023 | 3,729.00 |
| Mar 31, 2023 | 8,309.00 |
| Dec 31, 2022 | 31,606.00 |
| Sep 30, 2022 | 63,539.00 |
| Jun 30, 2022 | 102,479.00 |
| Mar 31, 2022 | 715,579.00 |